Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 35,020 | 37,201 | 28,930 | 28,560 | 26,179 |
| Operating Income | -35,020 | -37,201 | -28,930 | -28,560 | -26,179 |
| Other Income | 1,695 | 1,449 | 1,470 | 1,017 | 400 |
| Pre-tax Income | -33,325 | -35,752 | -27,460 | -27,543 | -25,779 |
| Net Income Continuous | -33,325 | -35,752 | -27,460 | -27,543 | -25,779 |
| Net Income | $-33,325 | $-35,752 | $-27,460 | $-27,543 | $-25,779 |
| EPS Basic Total Ops | -35.00 | -37.50 | -29.00 | -31.50 | -34.50 |
| EPS Basic Continuous Ops | -34.83 | -37.47 | -28.86 | -31.30 | -34.36 |
| EPS Diluted Total Ops | -35.00 | -37.50 | -29.00 | -31.50 | -34.50 |
| EPS Diluted Continuous Ops | -34.83 | -37.47 | -28.86 | -31.30 | -34.36 |
| EBITDA(a) | $-34,750 | $-36,911 | $-28,637 | $-28,262 | $-25,879 |